#EBVMS
🧬 New EBV-MS study: rituximab shows comparable effectiveness and safety to ocrelizumab in early MS, supporting more affordable access to high-efficacy treatment.

📖 buff.ly/QxpQvis

#MSResearch #EBVMS #HorizonEurope
Rituximab Matches Standard Therapy in Early MS: Key Results from the OVERLORD-MS Trial | UiB
A landmark study published in the New England Journal of Medicine provides strong evidence that a lower-cost treatment option for multiple sclerosis (MS) may perform as well as one of the current…
buff.ly
July 9, 2026 at 7:01 AM
🎙️ New MedTalk: Why do only some people with EBV develop MS?

Explore the roles of genetics, EBV strains, and AI in advancing MS research.

📖 buff.ly/THCgqaI
▶️ buff.ly/WBU4fZT

#EBVMS #HorizonEurope #MSresearch
Understanding EBV and MS: The Genetics Behind the Risk
A new MedTalk episode explores one of the most important and unresolved questions in neurology and immunology: how genetics and viral infection may together contribute to the development of Multiple…
buff.ly
July 7, 2026 at 7:00 AM
EMSP highlights its EU-funded projects this #WorldMSDay:
🔹 #WISDOM: secure data + AI for MS insights
🔹 #MoreEUROPA: better use of registry data for patient-centred care
🔹 #BEHINDMS: EBV’s role in MS via immune interactions
🔹 #EBVMS: why EBV leads to MS & antiviral approaches
May 29, 2026 at 8:00 AM
Sofia Ognibene presented a poster at the XIII Bioinformatics and Genomics Conference on a pipeline to analyze Epstein–Barr virus genomes in the context of the #EBVMS project 🧬🚀
Great work!
December 20, 2025 at 8:23 AM
Great days in Bergen for the EBV-MS consortium meeting. Inspiring discussions, outstanding science, and a truly collaborative spirit. Excited to be part of such a stimulating international effort to unravel the role of EBV in MS. #EBVMS #MultipleSclerosis
@researchmar.bsky.social
November 19, 2025 at 4:23 PM
At the EGA, we are proud to contribute to EBV-MS, the project aiming to unveil the role of the Epstein-Barr virus in the onset and progression of multiple sclerosis disease

👉 www.uib.no/en/ebvms
EBV-MS
EBV-MS is a ground-breaking Horizon Europe-funded research project aiming to unveil the role of the Eipstein-Barr virus (EBV) in the onset and progression of the Multiple Sclerosis (MS) disease.
www.uib.no
May 30, 2025 at 8:26 AM
We are proud to support the international research environments involved as partners in EBV-MS on their data management journey 🙌🚀

Find more information about the EBV-MS project here ↘️↘️
www.uib.no/en/ebvms
EBV-MS
EBV-MS is a ground-breaking Horizon Europe-funded research project aiming to unveil the role of the Eipstein-Barr virus (EBV) in the onset and progression of the Multiple Sclerosis (MS) disease.
www.uib.no
May 5, 2025 at 12:30 PM
#EBVMS integrates many data types, from various data resources 👩‍💻👨‍💻 Our contribution to the project is focused on #DataManagement

More info about the project ↘️ www.uib.no/en/ebvms
EBV-MS
EBV-MS is a ground-breaking Horizon Europe-funded research project aiming to unveil the role of the Eipstein-Barr virus (EBV) in the onset and progression of the Multiple Sclerosis (MS) disease.
www.uib.no
March 13, 2025 at 4:37 PM
#SetmanaMundialdelCervell

🧠 Podem aturar l'#EsclerosiMúltiple abans que comenci?

L'Hospital del Mar i @researchmar.bsky.social participen en el projecte #EBVMS sobre la seva relació amb el virus d'Epstein-Barr

➕ uib.no/en/ebvms

#BrainAwarenessWeek
March 13, 2025 at 12:12 PM
Everything ready for today's research #DataManagement training that our team has prepared for the #EBVMS Consortium members 🚀🙌

Learn more about this project targeting Epstein-Barr virus infection for treatment and prevention of #MultipleSclerosis ↘️
www.uib.no/en/ebvms
EBV-MS
EBV-MS is a ground-breaking Horizon Europe-funded research project aiming to unveil the role of the Eipstein-Barr virus (EBV) in the onset and progression of the Multiple Sclerosis (MS) disease.
www.uib.no
January 23, 2025 at 2:00 PM
November 16, 2024 at 11:50 AM